Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chao

Showing results (481-490 of 510) with videos related to

Pageof 51
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2022
Executive summary of American Radium Society's appropriate use criteria for the postoperative management of lower grade gliomasMartin C Tom, Michael T Milano, Samuel T Chao, et al.
Journal of Neuro-Oncology|August 11, 2018
Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancerNooshin Hashemi-Sadraei, Gaëlle M Müller-Greven, Fadi W Abdul-Karim, et al.
Advances in Radiation Oncology|June 12, 2025
Standard Dose Versus Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases (PROPS-BM) International Multicenter Cohort StudyRoshan S Prabhu, Rachel Russek, Zachary K Vaslow, et al.
Journal of Neuro-Oncology|April 29, 2022
Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomasDeborah Y Park, Martin C Tom, Yanwen Chen, et al.
JAMA Oncology|June 8, 2023
Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain MetastasesRoshan S Prabhu, Tobi Akinyelu, Zachary K Vaslow, et al.
Journal of Neuro-Oncology|June 21, 2023
<sup>18</sup>F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot studyMartin C Tom, Frank P DiFilippo, Stephen E Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2023
Single-Fraction Versus Fractionated Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort StudyRoshan S Prabhu, Tobi Akinyelu, Zachary K Vaslow, et al.
Journal of Neuro-Oncology|March 7, 2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancerPaul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics|August 29, 2019
Malignant Transformation of Molecularly Classified Adult Low-Grade GliomaMartin C Tom, Deborah Y J Park, Kailin Yang, et al.
Journal of Neuro-Oncology|January 22, 2022
Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade gliomaDeborah Y Park, Martin C Tom, Wei Wei, et al.
Pageof 51

Showing results (481-490 of 510) with videos related to

Sort By:
Pageof 51
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2022
Executive summary of American Radium Society's appropriate use criteria for the postoperative management of lower grade gliomasMartin C Tom, Michael T Milano, Samuel T Chao, et al.
Journal of Neuro-Oncology|August 11, 2018
Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancerNooshin Hashemi-Sadraei, Gaëlle M Müller-Greven, Fadi W Abdul-Karim, et al.
Advances in Radiation Oncology|June 12, 2025
Standard Dose Versus Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases (PROPS-BM) International Multicenter Cohort StudyRoshan S Prabhu, Rachel Russek, Zachary K Vaslow, et al.
Journal of Neuro-Oncology|April 29, 2022
Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomasDeborah Y Park, Martin C Tom, Yanwen Chen, et al.
JAMA Oncology|June 8, 2023
Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain MetastasesRoshan S Prabhu, Tobi Akinyelu, Zachary K Vaslow, et al.
Journal of Neuro-Oncology|June 21, 2023
<sup>18</sup>F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot studyMartin C Tom, Frank P DiFilippo, Stephen E Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2023
Single-Fraction Versus Fractionated Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort StudyRoshan S Prabhu, Tobi Akinyelu, Zachary K Vaslow, et al.
Journal of Neuro-Oncology|March 7, 2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancerPaul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics|August 29, 2019
Malignant Transformation of Molecularly Classified Adult Low-Grade GliomaMartin C Tom, Deborah Y J Park, Kailin Yang, et al.
Journal of Neuro-Oncology|January 22, 2022
Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade gliomaDeborah Y Park, Martin C Tom, Wei Wei, et al.
Pageof 51